Articles about Product Safety

home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Business Exposures

Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally

March 31, 2026

Via MarketMinute

Tickers ABBV AZN CORT IBB TEVA

Exposures Intellectual Property Product Safety US Equities

Biotech Defies Gravity: Sarepta and Corcept Lead Midday Healthcare Rally Amidst Market Volatility

March 31, 2026

Via MarketMinute

Topics Economy Intellectual Property Stocks

Tickers AAPL CORT MRK NVDA PFE REGN

Exposures Economy Intellectual Property Interest Rates

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Submits IND for TNBC Candidate Telomir-1

March 31, 2026

Via Investor Brand Network

Tickers TELO

Exposures Product Safety

Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability

March 31, 2026

Via Finterra

Topics Initial Public Offering

Tickers AZN BMY BNTX GS GSK JPM

Exposures COVID-19 Product Safety Securities Market

United Therapeutics Surges 14% on Groundbreaking Tyvaso Phase 3 Results for IPF

March 31, 2026

Via MarketMinute

Tickers BMY PLRX RHHBY UTHR

Exposures Product Safety

Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance

March 31, 2026

Via Finterra

Topics Lawsuit Product Recall

Tickers ABT BSX JNJ MDT

Exposures Financial Legal Product Safety

Soligenix Inc. (NASDAQ: SNGX) Expands Pipeline Momentum as SGX945 Earns Global Recognition

March 31, 2026

Via Investor Brand Network

Tickers SNGX

Exposures Product Safety

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data for Lyme Disease Candidate TNX-4800, Plans Phase 2 Study

March 31, 2026

Via Investor Brand Network

Tickers TNXP

Exposures Product Safety

The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals

March 31, 2026

Via Finterra

Topics Economy Initial Public Offering Intellectual Property

Tickers ALKS CNTA GS JAZZ LLY TAK

Exposures Intellectual Property Interest Rates Product Safety

The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience

March 31, 2026

Via Finterra

Topics Economy Intellectual Property

Tickers BIIB BLK CNTA LLY NVO RHHBY

Exposures Intellectual Property Interest Rates Product Safety

Bionic Intelligence Research Agent Now Commercially Live for Secure, Scalable, Autonomous Solutions in Global Biotech and Pharma Industries: KALA BIO, Inc. (Nasdaq: KALA)

March 31, 2026

Via Get News

Topics Artificial Intelligence Intellectual Property

Tickers KALA

Exposures Artificial Intelligence Intellectual Property Product Safety

Agios Pharma Rallies On A Surprise FDA Move In Sickle Cell Disease ↗

March 31, 2026

Via Investor's Business Daily

Exposures Product Safety

BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch

March 31, 2026

Via Investor Brand Network

Tickers BMWYY NTRB

Exposures Product Safety

BioMedNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Advances AI-Driven Oncology Pipeline With Multiple 2026 Milestones in View

March 31, 2026

Via Investor Brand Network

Topics Artificial Intelligence

Tickers BMWYY LTRN

Exposures Artificial Intelligence Product Safety

2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More ↗

March 31, 2026

Via The Motley Fool

Tickers HCA LLY VKTX

Exposures Product Safety

OS Therapies Completes Submission of Biomarker & Clinical Data for U.S. FDA Pre-BLA Meeting, Reports Full Year 2025 Financial Results and Provides Business Update

March 31, 2026

Via Newsfile

Tickers OSTX

Exposures Product Safety

Why Is PepGen Stock Sinking Tuesday? ↗

March 31, 2026

Via Benzinga

Exposures Product Safety

AI-Powered “Depression Thermometer” to Aid Interventional Psychiatry Network via Strategic Partnership with Emobot for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

March 30, 2026

Via Get News

Tickers NRXP

Exposures Product Safety

NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge

March 30, 2026

Via PRLog

Topics Artificial Intelligence

Exposures Artificial Intelligence Product Safety

Biogen Stock Pops After FDA Approves New High-Dose Spinraza For Spinal Muscular Atrophy ↗

March 30, 2026

Via Benzinga

Exposures Product Safety

From Shenzhen to the World: How Sunflower Dental Lab Became a Global Leading Dental Implant Service Powerhouse

March 30, 2026

Via AB Newswire

Topics Artificial Intelligence

Exposures Artificial Intelligence Product Safety

CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis

March 30, 2026

Via PRLog

Topics Death

Exposures Death Product Safety

Sysco’s $29 Billion Bet: Foodservice Giant Swallows Jetro Restaurant Depot to Dominate Cash-and-Carry Market

March 30, 2026

Via MarketMinute

Topics Economy

Tickers ARM COST PFGC SYY USFD WMT

Exposures Interest Rates Product Safety Supply Chain

MoonLake Says Lead Drug Shows Durable Response, Eyes FDA Filing ↗

March 30, 2026

Via Benzinga

Exposures Product Safety

Industrial Intelligence: Stellantis’ High-Stakes AI Pivot with Palantir

March 30, 2026

Via Finterra

Topics Artificial Intelligence Economy Product Recall

Tickers BYDDY F GM PLTR STLA TSLA

Exposures Artificial Intelligence Interest Rates Legal

Altria's Oral Nicotine Pouch Product Is Going Nationwide. Is the Stock a Buy in 2026? ↗

March 30, 2026

Via The Motley Fool

Tickers MO

Exposures Product Safety

Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762

March 30, 2026

Via Newsfile

Tickers PHIO

Exposures Product Safety

CCHR: Time to End the Psychotropic Pill Epidemic – National Adverse Drug Event Awareness Day Exposes America’s Hidden Medication Crisis

March 30, 2026

Via Send2Press

Topics Death

Exposures Death Product Safety

Psilocybin-Assisted Therapy: A Modern Approach to Mental Health Innovation

March 30, 2026

Via BusinesNews Wire

Exposures Product Safety

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

March 28, 2026

Via TheNewswire.com

Topics Fraud Lawsuit

Tickers QURE

Exposures Financial Legal Product Safety

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com